Johnson, Douglas B <br/><br/>
Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131).  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  04 2020 
 - 1812-1819 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-19-3443  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Female<br/>Humans<br/>Lymphoma--drug therapy<br/>Male<br/>Middle Aged<br/>Mutation<br/>National Cancer Institute (U.S.)<br/>Neoplasms--drug therapy<br/>Oncogene Proteins, Fusion<br/>Protein Kinase Inhibitors--therapeutic use<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Pyridones--therapeutic use<br/>Pyrimidinones--therapeutic use<br/>Survival Rate<br/>Treatment Outcome<br/>United States